Audited Results of Concord Biotech Ltd. Company

(Rs in Cr.) Mar 31, 2025 Mar 31, 2024 Mar 31, 2023
Operating Income 1,200.09 1,016.94 853.17
Manufacturing Expenses 112.23 104.97 97.65
Personnel Expenses 138.93 123.05 110.28
Selling Expenses 0 0 0
Administrative Expenses 124.89 115.76 108.68
Expenses Capitalised 0 0 0
Cost Of Sales 693.76 585.38 509.88
Operating Profit 506.33 431.56 343.29
Other Recurring Income 44.45 33.78 35.31
Adjusted PBDIT 550.78 465.34 378.60
Financial Expenses 0.53 2.55 4.51
Depreciation 54.37 53.59 54.03
Other Write offs 0 0 0
Adjusted PBT 495.88 409.19 320.05
Tax Charges 122.91 104.46 81.93
Adjusted PAT 372.96 304.73 238.13
Non Recurring Items 5.97 -0.01 0.26
Other Non Cash adjustments 0 0 0
Reported Net Profit 372.96 304.73 238.13
Equity Dividend 91.54 71.45 53.56
Preference Dividend 0 0 0
Retained Earnings 1,691 1,403.60 1,170.33

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article

Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
  • Block for 8 hours
  • Block for 12 hours
  • Block for 24 hours
  • Don't block
Gender
Select your Gender
  • Male
  • Female
  • Others
Age
Select your Age Range
  • Under 18
  • 18 to 25
  • 26 to 35
  • 36 to 45
  • 45 to 55
  • 55+